# Gemini Bio opens new cGMP manufacturing facility in West Sacramento

Gemini Bioproducts opened a new 25,000-square-foot cGMP manufacturing facility in West Sacramento, California, quadrupling production capacity for cell culture reagents.

- Type: New facility
- Announced: 2020-06-19
- Where: West Sacramento, California, United States
- Starts operating: 19 Jun 2020
- Status: completed
- Capacity: 25,000 sq ft facility
- Products: cell culture media, sera, buffers, reagents
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Gemini Bioproducts](https://endata.com/companies/48004.md)

## Sources

- [newswire.com](https://www.newswire.com/news/gemini-bio-opens-new-cgmp-facility-21163773), 2020-06-19: "Gemini Bio’s new facility was built to support the production of cell culture media, sera, buffers, and other reagents with products that serve the cell and gene therapy market."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
